Material Insights · Understanding the Material World

Vaccines: Use case

Use cases

Each use, its share of demand and volume, how critical the product is to it and why, and the price paid

Use caseShare of demandVolumeUnitCriticalityReasonYearSource
Routine childhood immunisation in countries supplied through UNICEF– 2.79 billiondoses UNICEF delivered to 99 countriesEssentialJudgement: no medicine replaces prevention for most vaccine-preventable diseases; WHO says vaccination accounts for 40% of the fall in infant deaths worldwide.2024[4][1]
Self-procuring middle-income countries (share of 2023 market volume, approximately)40%– – EssentialJudgement: national programmes buy for routine schedules.2023[2]
Pooled procurement by UNICEF and PAHO (share of globally procured volume)36%– – EssentialJudgement: pooled buying supplies low-income and Gavi-supported programmes.2023[2]
Self-procuring high-income countries (the remaining share of 2023 market volume)24%– – EssentialJudgement: national programmes buy for routine schedules; this group holds 72% of market value.2023[2]
India's Universal Immunisation Programme, free immunisation against 12 diseases: newborns targeted a year (2.67 crore)– 26.7 millionnewborns targeted a year (calculated: 2.67 crore converted)EssentialJudgement: the state programme is the main route to immunisation for most Indian children.2024[14]
India's Universal Immunisation Programme: pregnant women targeted a year (2.9 crore)– 29 millionpregnant women targeted a year (calculated: 2.9 crore converted)EssentialJudgement: the state programme gives the vaccines in routine antenatal care.2024[14]
Outbreak response from Gavi-supported emergency stockpiles– 63uses of Gavi-supported emergency stockpiles (cholera, Ebola, meningococcal and yellow fever vaccines) by 19 countriesImportantJudgement: stockpiles are for outbreaks; routine programmes cover most doses.2025[13]

as of 2026-11-14

Industries that buy it

The industries and kinds of firm that buy it, for which use case, and how critical it is to them

Used by
  • Healthcare services Immunisation of children and pregnant women · criticality essential Health workers carry vaccines from the country store to villages in cold boxes and vaccine carriers [10]; no share of demand by facility type was found.

as of 2026-11-14

What it competes with

The products and technologies that compete with it in each use case

Competes with
  • Antibiotic medicines Preventing bacterial infections and the antibiotic use that follows Only a partial swap, for the diseases that have a vaccine. WHO estimates that vaccines against 23 pathogens, including some still to be developed, could reduce the number of antibiotics needed by 22%, or 2.5 billion defined daily doses a year [26]; no cost comparison was found.

as of 2026-11-14

How it is used

Lifetime, use per year and utilisation, by variant

MeasureValueUnitPlaceYearSource
Vaccine wastage assumed in UNICEF's costing, BCG (20-dose vial)54% of dosesWorld (Gavi-eligible countries)2024[8]
Vaccine wastage assumed in UNICEF's costing, pneumococcal conjugate (4-dose vial)17% of dosesWorld (Gavi-eligible countries)2024[8]
Wastage at service delivery points (the study's last cold chain point), measles vaccine31.47% of dosesIndia2019[16]
Wastage at service delivery points (the study's last cold chain point), BCG vaccine56.83% of dosesIndia2019[16]
Wastage at service delivery points (the study's last cold chain point), pneumococcal conjugate vaccine0.24% of dosesIndia2019[16]
Wastage by vial size: vaccines in 10-dose vials (BCG, pentavalent, rotavirus, JE, DPT, TT)33.61% of dosesIndia2019[16]
Wastage by vial size: vaccines in vials of 5 doses or fewer (measles, PCV)15.91% of dosesIndia2019[16]
Vaccine doses recorded on India's U-WIN platform as of 16 September 2024 (calculated: 23.06 crore converted)231 milliondoses (converted from crore)India2024[14]

as of 2026-11-14

Prices

Unit prices by market or use, with year and source

MarketValueUnitYearSource
UNICEF price for Gavi-eligible countries, oral polio vaccine0.14US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, DTP vaccine (second year of life)0.19US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, BCG vaccine0.2US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, measles-rubella vaccine0.82US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, pentavalent vaccine0.84US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, injectable polio vaccine2.1US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, rotavirus vaccine2.22US$ per dose2024[8]
UNICEF price for Gavi-eligible countries, pneumococcal conjugate vaccine (PCV13)2.75US$ per dose2024[8]
Average cost of fully vaccinating one child (eleven diseases, Gavi-eligible countries; range US$45.51 to US$129.57)73.15US$ per child2024[8]
High-income countries' share of the world market's financial value72% of value2023[2]

as of 2026-11-14

Sources

  1. Global vaccine market report 2024 World Health Organization, 2024, landing page, published 19 December 2024; data for 2023; WHO lists a final version (B09198, 3 February 2025)
  2. WHO releases global vaccine market report 2024 Immunization Economics (summary of the WHO report), 2025, 17 February 2025
  3. UNICEF Supply Annual Report 2024 UNICEF Supply Division, 2025
  4. Costs of Fully Vaccinating a Child: Countries Eligible for Gavi Vaccine Prices UNICEF, 2024, August 2024; Tables 1 and 4
  5. What is a cold chain? UNICEF Supply Division
  6. Facts and figures Gavi, the Vaccine Alliance, 2026, figures for 2000 to 2025
  7. World Immunization Day 2024: India's Immunization Drive: A Commitment to Universal Vaccine Coverage and Health Equity Ministry of Health and Family Welfare, Government of India (PIB), 2024, 7 November 2024
  8. National Vaccine Wastage Assessment 2019 NCCVMRC-NIHFW and UNICEF India, 2019, fieldwork February to March 2019 on a review period of April to September 2018; Tables 2, 6 and 11 and section 4.1
  9. Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO World Health Organization, 2024, 10 October 2024